We remain very committed to delivering innovative and high-quality solutions and making
meaningful contribution to the communitieswe operate in.
Dear Shareholders,
It is our proud privilege to place the 32 Annual Report for the year ended 31"
March, 2024. hope this letter finds youin good health and spirits.
In the dynamic landscape of the pharmaceutical industry, marked by significant
transformation and evolving challenges, Kilitch stands steady, leading with purpose,
proactively managing risk and charting new territories.
We are setting up a New Green Field projects at Pen Maharashtra India, a facility to
produce Oral Tablets, Liquid Injectable Vials, Liquid Injectable Ampules, Opthalmic Drops
and Nasal Drops. By expanding our own manufacturing capabilities, we aim the production of
high-quality products, establish a robust supply chain, reducing our dependence on
outsourcing and reach out the demand globally. This move will enable us to make a greater
impact in both the domestic as wellas international markets.
Our manufacturing plant in Mumbai is equipped with a dedicated dry powder section,
ophthalmic products as well as the capacity to produce small volume liquid ampoules and
vials. With the foreseen of increasing demand and market potential in the year 2025-26, we
have doubled our manufacturing capacity of Opthalmic products at Mumbai Plant. Our product
range encompasses OSD, Parenteral, Nasal Products, Opthalmic Products, Nutritional
Products, Medical Devices and Cosmetics Products. With our strong product portfolio,we are
well positionedto leverage our existing customers & markets and targeting new market
opportunities and we also acknowledge a very high retention rate of customers.
Our Manufacturing Unit at Ethiopia, which is the largest Cephalosporin facility in East
Africa led to positive growth. Since its commencement till now, we are working hard to
take drive it towards a greater height while achieving milestone. The Government supply
tender of USD 9.13 million awarded in Ethiopia is another notable achievement of this year
which enables us to overcome our difficulties of shortage of foreign reserves. These
orders are most likely to continue and growin coming years.
Our dedicated efforts in product development, market penetration, robust supply chain,
regulatory compliance and corporate governance practices are driving our way ahead. We
remain very committed to delivering innovative and high-quality solutions and making
meaningful contribution to the communities we operate in. As a responsible business
organisation, we are committed to the present and future need of our employees,
communities and planet while enhancing value for our stakeholders.
We express our sincere appreciation and gratitude to all our employees, shareholders,
Governments of India as well as foreign countries and all other associates for their
continued faith, support and confidence towards us. It is your support and trust in us
that strengthens our commitmentsto excellence.
| Warm Regards, |
| Mukund Mehta |
| Managing Director |